العلاج الكيميائي الإشعاعي بعد الجراحة لسرطان تجويف الفم ذي السمات المرضية عالية الخطورة

References

• For patients at high risk of recurrence, adjuvant treatment using radiation therapy or chemoradiation is often used.
• The established standard of care for patients with high-risk features (pENE and/or positive margins) is postoperative concurrent CRT with high-dose cisplatin at 100 mg/m2 once every 3 weeks.
• In cisplatin-eligible patients, the standard of care for OSCC with high-risk features is high-dose cisplatin 100 mg/m2 once every 3 weeks or lower-dose cisplatin 40 mg/m2 once weekly, which should be added concurrently to radiotherapy.

DOI: 10.1200/EDBK_389810